Abbott Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ABBOTT, and what generic and branded alternatives to ABBOTT drugs are available?
ABBOTT has one hundred and eleven approved drugs.
Drugs and US Patents for Abbott
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbott | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | INJECTABLE;INJECTION | 084223-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Abbott | VERCYTE | pipobroman | TABLET;ORAL | 016245-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Abbott | AMINOSYN II 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER | amino acids; dextrose | INJECTABLE;INJECTION | 019713-001 | Sep 9, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Abbott | AMINOSYN 3.5% M IN PLASTIC CONTAINER | amino acids; magnesium acetate; phosphoric acid; potassium acetate; sodium chloride | INJECTABLE;INJECTION | 018804-002 | May 15, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Abbott
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbott | MERIDIA | sibutramine hydrochloride | CAPSULE;ORAL | 020632-002 | Nov 22, 1997 | 4,929,629*PED | ⤷ Try a Trial |
Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-004 | Aug 7, 1987 | 4,112,097 | ⤷ Try a Trial |
Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-003 | Aug 7, 1987 | 5,212,176 | ⤷ Try a Trial |
Abbott | DEPAKOTE CP | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 019794-001 | Jul 11, 1990 | 4,988,731*PED | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ABBOTT drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Capsules | 10 mg and 15 mg | ➤ Subscribe | 2009-08-14 |
➤ Subscribe | Capsules | 100 mg | ➤ Subscribe | 2012-10-31 |
➤ Subscribe | Tablets | 100 mg | ➤ Subscribe | 2010-12-21 |
Similar Applicant Names
Here is a list of applicants with similar names.